Dretacen

Dretacen is an antiepileptic medication containing Levetiracetam, used to manage seizures. This oral medication is manufactured by Sandoz S.R.O. and is available in the EU market.

Dretacen is primarily used as an adjunctive therapy for partial-onset seizures in adults and children. It is also prescribed for myoclonic seizures in adults and children with juvenile myoclonic epilepsy. Levetiracetam, the active ingredient, works by stabilizing electrical activity in the brain, helping to prevent seizures. Patients often wonder, 'What is Dretacen used for?' and the answer lies in its effectiveness in managing various types of seizures.

Common effects of Dretacen may include drowsiness, dizziness, and fatigue. Some users report headaches or nausea. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider. The medication's impact can vary from person to person, so individual experiences may differ.

Dretacen should be handled with care, especially for those with a history of mental health issues or kidney problems. It is important to follow the prescribed dosage and not to abruptly stop taking the medication without consulting a healthcare provider. Pregnant or breastfeeding women should discuss the risks and benefits with their doctor before using Dretacen.

Dretacen may interact with other medications, including those that affect the central nervous system. Alcohol consumption should be avoided as it can enhance the sedative effects of Levetiracetam. It is also important to inform your healthcare provider about all other medications you are taking to avoid potential interactions.